Potassium Acid Blocker No Better Than PPI for Artificial Gastric Ulcers Small Japanese trial found similar outcomes with both drugs May 25, 2021
GI Disruption Lasts for Months in Many COVID Survivors Persistently loose stools were most common after-effect May 24, 2021
Microbiome Therapies for Recurrent C. Diff Advance Clinical trial success for two proprietary bacteria mixtures May 22, 2021
These Risk Factors Can Make Severe Pancreatitis Worse Not surprisingly, clinical outcomes also suffered May 20, 2021
Probiotics Protect Overweight, Older Patients From Coughs and Wheeze Trial affirms "gut-lung" link but with important caveats May 14, 2021
Adding GLP-1 Drug Makes Sleeve Gastroplasty a Diabetes Treatment Endoscopic procedure could yield benefits now seen only with more invasive surgery May 14, 2021
Pandemic Drinking Took Swift Toll on the Gut, Liver Alcohol-related inpatient consults soared, remained high even after reopening May 14, 2021
Is Dynamic AFP-R Key to Transplant Selection in Liver Cancer? Dynamic alpha-fetoprotein response improved prediction of patient outcomes May 05, 2021
Results Disappoint for Fecal Transplant in Arthritis But interest persists in targeting the gut-joint axis in psoriatic arthritis May 04, 2021
'It's a Straw-Man Argument': What We Heard This Week Quotable quotes from ΒιΆΉ΄«Γ½'s sources May 02, 2021
New Option for Eosinophilic Esophagitis? Special budesonide formulation topped placebo across a range of outcomes Apr 21, 2021
Can an Agile Endoscopic Device Curb PPI-Dependent GERD? GERDx device improved quality of life; not so much for esophageal acid exposure Apr 16, 2021
Perianal Involvement in Crohnβs Disease: How Bad for Prognosis? Poor outcomes noted, especially with severe phenotype Apr 14, 2021
Another FGFR Inhibitor Active in Bile Duct Cancers Clinical benefit rate of 82% in patients selected for FGFR2 fusions, rearrangements Apr 13, 2021
Can a COX-2 Inhibitor Boost Disease-free Survival in CRC? Large trial tested addition of the agent to standard FOLFOX Apr 06, 2021
Refractory IBD: The Case for Doubling Up on Drugs Meta-analysis suggests select patients can avoid surgery Apr 01, 2021
Minimizing the Pesky Placebo Response in IBS Trials Identifying the determinants is key to better trial design Mar 26, 2021
No Help From Extra Hydration to Prevent Post-ERCP Pancreatitis Trial may settle whether aggressive, laborious procedure is justified Mar 18, 2021
Game Changer for Ulcerative Colitis Patients Failing Anti-TNF? JAK inhibitor helped when biologic didn't Mar 12, 2021
New Guideline Lowers Age to Begin Colorectal Cancer Screening Update comes as incidence has doubled in people under 50 Mar 09, 2021
Vedolizumab Tied to Lower Risk for Serious Infections in Ulcerative Colitis But positive association versus TNF inhibitors not seen in Crohn's disease Mar 01, 2021
Antibiotic Duo Wins in Diverticulitis Outpatient Tx Less risk for harms without adversely affecting outcomes, cohort studies show Feb 22, 2021
AGA Updates Guidelines for Refractory H. Pylori New info stresses knowing patients' antibiotic exposure and doing drug susceptibility testing Feb 01, 2021
JAK Inhibitor Misses Endpoint in Safety Study. Now What? Major blow to popular class of oral rheumatology drugs Jan 27, 2021
IBD and COVID: Kids Do Well International registry shows older age, comorbidities are risks; anti-TNF might protect Jan 25, 2021
Aspirin and CRC Risk: A Curious Age Connection Implications for prophylactic recommendations, researchers say Jan 21, 2021
Drug Hits Target in Advanced Biliary Cancer Responses in up to a third of patients with FGFR inhibitor infigratinib Jan 19, 2021
New Target to Attack in Stomach Cancer PFS, OS improved with fibroblast growth factor receptor inhibitor in non-HER2 disease Jan 16, 2021
Gut Microbiome and COVID-19 Severity: New Evidence for Link Lab study finds certain patterns associated with more serious illness Jan 11, 2021
COVID-19: A Clear Affinity for the Digestive System GI manifestations may be a red flag for more severe disease and worse outcomes Jan 04, 2021
Diet Curbs GERD Beyond Acid Suppressants Study finds five anti-reflux behaviors could prevent almost 40% of the symptoms in women Jan 04, 2021
Laparoscopic Lavage a Safe Option in Perforated Diverticulitis No difference versus resection in long-term severe complications, but recurrence more common Dec 29, 2020
GI Bleeds Tied to Worse Prognosis for COVID-19 Inpatients Anticoagulation or antiplatelet agents not tied to higher risk of bleeding in cohort study Dec 22, 2020
Young-Onset Esophageal Cancer Rapidly Increasing Physicians should be on the alert for younger patients with dysphagia, researchers urge Dec 16, 2020
IBD and COVID-19: Who Is at Risk? Worse outcomes for older patients and those with comorbidities and on steroids Dec 12, 2020
Can Some Treatments Be Stopped in IBD? With combination therapy, some patients successfully withdrew the TNF inhibitor Dec 11, 2020
Ozanimod a Winner in Ulcerative Colitis S1P receptor modulator effective for both induction and maintenance Dec 10, 2020
